Evidence map›Paper›PMID 23415265›Full record

ReviewClinics in perinatology2013

Lactoferrin and necrotizing enterocolitis.

Michael P Sherman

Open access · greenAbstract readReview
In one paragraph

Review in Clinics in perinatology, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 19 papers.

0numbers the graph read from it
0cells of the map it votes in
19citing papers in PubMed
4.2field-weighted citation impact, top 6% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

19 citing papers in PubMed, 48 citations in OpenAlex.

  1. Review
  2. Review
  3. Review
  4. Article
  5. Review
  6. Review
  7. Article
  8. Children were less frequently infected with SARS-CoV-2 than adults during 2020 COVID-19 pandemic in Warsaw, Poland.European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology · 2021
    Article
  9. Preterm neonatal immunology at the intestinal interface.Cellular and molecular life sciences : CMLS · 2020
    Review
  10. Review
  11. Article
  12. Article
  13. Review
  14. Necrotizing enterocolitis: new insights into pathogenesis and mechanisms.Nature reviews. Gastroenterology & hepatology · 2016
    Review
  15. Review
  16. Review
  17. Review
  18. Review
  19. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

1 author at 1 institution in 1 country.

Michael P ShermanDivision of Neonatology, Women's and Children's Hospital, University of Missouri Health System, University of Missouri, Suite 206, 404 Keene Street, Columbia, MO 65201, USA. ShermanMP@health.missouri.edu
University of Missouri Health System · US

Funding

Lactoferrin Enhances Growth and Reduces Nosocomial Infection in Preterm InfantsR44HD057744 · NICHD · AGENNIX, INC. · PI PETRAK, KAREL · 2008 to 2009
$1.1M
NICHD NIH HHS HD057744NICHD NIH HHS R44 HD057744
6 · The paper itself

Abstract

Lactoferrin (LF) is a multifunctional protein and a member of the transferrin family. LF and lysozyme in breast milk kill bacteria. In the stomach, pepsin digests and releases a potent peptide antibiotic called lactoferricin from native LF. The antimicrobial characteristics of LF may facilitate a healthy intestinal microbiome. LF is the major whey in human milk; its highest concentration is in colostrum. This fact highlights early feeding of colostrum and also fresh mature milk as a way to prevent necrotizing enterocolitis.

Indexed as

AnimalsColostrumEnterocolitis, NecrotizingHumansInfant, NewbornIntestine, SmallLactoferrinMetagenomeMilkMilk, HumanMuramidaseLactoferrinMuramidase

Identifiers

PMID23415265
PMCPMC3579561
OpenAlexW2064704817

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.